Cargando…
In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cells
We have investigated the effects of the low-toxic retinoid, all-trans retinoyl β-glucuronide (RAG) alone and in combination with the phenylacetate (PA) derivative 4-chloro-phenylacetate (4-CPA) on the human neuroblastoma cell line, LA-N-5. In vitro studies demonstrated that RAG and 4-CPA treatments...
Autores principales: | Sidell, N, Pasquali, M, Malkapuram, S, Barua, A B, Wanichkul, T, Wada, R K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394242/ https://www.ncbi.nlm.nih.gov/pubmed/12865937 http://dx.doi.org/10.1038/sj.bjc.6601108 |
Ejemplares similares
-
The retinoid anticancer signal: mechanisms of target gene regulation
por: Liu, T, et al.
Publicado: (2005) -
In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010) -
A STUDY ON THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA WITH RETINOIDS AND SURGICAL EXCISION
por: Puri, Neerja, et al.
Publicado: (2011) -
Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo
por: Armstrong, J L, et al.
Publicado: (2007) -
No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan
por: Calvet, L, et al.
Publicado: (2004)